Back to 
Pacer Advisors, Inc.
Pacer Advisors, Inc.
KNSA
Showing 1 of 2 quarters
Position history for Pacer Advisors, Inc.'s holdings in Kiniksa Pharmaceuticals International, plc
No. Pacer Advisors exited its KNSA (Kiniksa Pharmaceuticals International) position in Q3 2024. Its Q2 2024 13F listed 345 shares worth $6,441. Pacer Advisors already held KNSA in its Q2 2024 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History